SARS-COV2 vaccine (DreamTec Research)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSARS-COV2 vaccine (DreamTec Research)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Pneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIranHong Kong
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesDreamTec Research Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDreamTec Research Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Pneumonia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A